EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Endothelial Heterogeneity in Pulmonary Hypertension

Hanqiu Zhao, Murali M Chakinala iD, Michael B Fallon iD, Susan M Lin, Janet S Lee iD, Zhiyu Dai iD

Arteriosclerosis, Thrombosis, and Vascular Biology · 2026-01 · 46 (1) · 3-16

DOI: 10.1161/atvbaha.125.322482 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2026-01. Verfasst von Hanqiu Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine in St. Louis, MO (H.Z., M.M.C., S.…. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Endothelial Cells, Vascular Remodeling, Lung. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The lung endothelium is essential for maintaining normal lung structure and plays a key role in gas exchange, barrier function, angiogenesis, vascular tone, and inflammation regulation. The advent of single-cell RNA sequencing has revealed the unique heterogeneity of pulmonary endothelial cells (ECs) in their function, morphology, and localization. Pulmonary hypertension (PH) is a progressive vascular disorder marked by elevated pulmonary arterial pressure and vascular remodeling. Central to its pathogenesis is EC dysfunction, and emerging evidence highlights EC heterogeneity in driving the complexity of PH. The distinct lung endothelial subpopulations exhibit diverse molecular signatures and functional responses under PH. A complete picture of how these different subpopulations contribute to vascular remodeling of PH is critical to identify novel therapeutic opportunities. This brief review summarizes recent insights into EC dysfunction in PH, focusing on the role of specialized EC subsets and novel therapeutic strategies targeting EC dysfunction. We highlight the integration of cutting-edge technologies in understanding how endothelial heterogeneity shapes the trajectory of PH and opens new avenues for future therapeutic innovations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypertension, PulmonaryEndothelial CellsVascular RemodelingLungEndothelium, VascularPulmonary ArteryHumansAnimalsPhenotype

Stichwörter der Autor:innen

capillariesendothelial cellshypertension, pulmonarypulmonary arterial hypertensionvascular remodeling

Autor:innen und Institutionen

  • Division of Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine in St. Louis, MO (H.Z., M.M.C., S.M.L., J.S.L., Z.D.).
  • Department of Internal Medicine, College of Medicine-Phoenix, The University of Arizona, Phoenix (M.B.F.).

ORCID-Profile: Murali M Chakinala, Michael B Fallon, Janet S Lee, Zhiyu Dai

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Zhao, H., Chakinala, M. M., Fallon, M. B., Lin, S. M., Lee, J. S., & Dai, Z. (2026). Endothelial Heterogeneity in Pulmonary Hypertension. Arteriosclerosis, Thrombosis, and Vascular Biology, 46(1), 3-16. https://doi.org/10.1161/atvbaha.125.322482

Vancouver

Zhao H, Chakinala MM, Fallon MB, Lin SM, Lee JS, Dai Z. Endothelial Heterogeneity in Pulmonary Hypertension. Arteriosclerosis, Thrombosis, and Vascular Biology. 2026;46(1):3-16. doi:10.1161/atvbaha.125.322482

BibTeX
@article{Zhao2026,
  author = {Zhao, Hanqiu and Chakinala, Murali M and Fallon, Michael B and Lin, Susan M and Lee, Janet S and Dai, Zhiyu},
  title = {Endothelial Heterogeneity in Pulmonary Hypertension},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2026},
  volume = {46},
  number = {1},
  pages = {3--16},
  doi = {10.1161/atvbaha.125.322482}
}
Kostenlos starten →